نتایج جستجو برای: topoisomerase inhibitors

تعداد نتایج: 194843  

Journal: :GSC biological and pharmaceutical sciences 2021

Topoisomerase II alpha catalyses and guides the unknotting of DNA by creating double transient breaks in using a conserved tyrosine as catalytic residue. has been shown to be overexpressed numerous types cancers it is target for multiple chemotherapeutic agents. Many topoisomerase inhibitors have identified from natural sources reviewed many reports anticancer In present study, total 240 phytoc...

2015
Nan Ma Ying Wang Bing-Xin Zhao Wen-Cai Ye Sheng Jiang

The copper(I)-catalyzed 1,3-dipolar cycloaddition between alkynes and azides (click chemistry) to form 1,2,3-triazoles is the most popular reaction due to its reliability, specificity, and biocompatibility. This reaction has the potential to shorten procedures, and render more efficient lead identification and optimization procedures in medicinal chemistry, which is a powerful modular synthetic...

Journal: :Cancer research 1993
M K Danks M R Warmoth E Friche B Granzen B Y Bugg W G Harker L A Zwelling B W Futscher D P Suttle W T Beck

Five cell lines selected for resistance to the cytotoxicity of inhibitors of DNA topoisomerase II have point mutations in the gene that codes for the M(r) 170,000 form of this enzyme. In each case, the mutation results in an amino acid change in or near an ATP binding sequence of the M(r) 170,000 isozyme of topoisomerase II. We used single-strand conformational polymorphism analysis to screen f...

2014
Cinzia Tesauro Grazia Graziani Barbara Arnò Laura Zuccaro Alessia Muzi Ilda D’Annessa Elettra Santori Lucio Tentori Carlo Leonetti Paola Fiorani Alessandro Desideri

BACKGROUND DNA topoisomerases are key enzymes that modulate the topological state of DNA through the breaking and rejoining of DNA strands. Human topoisomerase I belongs to the family of poly(ADP-ribose)-binding proteins and is the target of camptothecin derived anticancer drugs. Poly(ADP-ribosyl)ation occurs at specific sites of the enzyme inhibiting the cleavage and enhancing the religation s...

Journal: :Molecular pharmacology 2013
David L Hermanson Sonia G Das Yunfang Li Chengguo Xing

Drug resistance is a serious challenge in cancer treatment and can be acquired through multiple mechanisms. These molecular changes may introduce varied extents of resistance to different therapies and need to be characterized for optimal therapy choice. A recently discovered small molecule, ethyl-2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate) (CXL017), revea...

Journal: :Cancer research 2001
B Ng E Kramer L Liebes C Wasserheit H Hochster E Blank R Ceriani P Furmanski

Clinical radioimmunotherapy (RIT) of solid tumors holds great promise, but as yet has been unable to deliver tumoricidal radiation doses without unacceptable toxicity. Our experimental approach aims to potentiate the therapeutic action of radioimmunoconjugates at the tumor site and thus improve the efficacy of RIT by combination with other treatment modalities. The topoisomerase I inhibitors ar...

Journal: :Molecular pharmacology 2000
T Syrovets B Büchele E Gedig J R Slupsky T Simmet

Acetyl-boswellic acids (acetyl-BA) are pentacyclic triterpenes derived from the gum resin of frankincense. We have previously shown that these compounds are effective cytotoxic agents, acting through a mechanism that appears to involve the inhibition of topoisomerase activity. We have now investigated the mechanism of action of acetyl-BA and show that these compounds are more potent inhibitors ...

2016
Peter Hornyak Trevor Askwith Sarah Walker Emilia Komulainen Michael Paradowski Lewis E. Pennicott Edward J. Bartlett Nigel C. Brissett Ali Raoof Mandy Watson Allan M. Jordan Donald J. Ogilvie Simon E. Ward John R. Atack Laurence H. Pearl Keith W. Caldecott Antony W. Oliver

Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a 5'-tyrosyl DNA phosphodiesterase important for the repair of DNA adducts generated by non-productive (abortive) activity of topoisomerase II (TOP2). TDP2 facilitates therapeutic resistance to topoisomerase poisons, which are widely used in the treatment of a range of cancer types. Consequently, TDP2 is an interesting target for the development of smal...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید